APA (7th ed.) Citation

Q, W., M, Z., QY, Z., H, Z., JD, D., K, H., . . . PF, S. (2026). The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer. Asian journal of andrology, 28(3), 304. https://doi.org/10.4103/aja202520

Chicago Style (17th ed.) Citation

Q, Wang, et al. "The Prognostic Significance of Prostate-specific Antigen Dynamics During Abiraterone Therapy in Patients with High-risk Metastatic Hormone-sensitive Prostate Cancer." Asian Journal of Andrology 28, no. 3 (2026): 304. https://doi.org/10.4103/aja202520.

MLA (9th ed.) Citation

Q, Wang, et al. "The Prognostic Significance of Prostate-specific Antigen Dynamics During Abiraterone Therapy in Patients with High-risk Metastatic Hormone-sensitive Prostate Cancer." Asian Journal of Andrology, vol. 28, no. 3, 2026, p. 304, https://doi.org/10.4103/aja202520.